illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Yichang HEC Changjiang Pharmaceutical
Company logo

Yichang HEC Changjiang Pharmaceutical | Sustainability Performance

https://www.hec-changjiang.com/en/index.aspx
Linkedin

Produces and markets pharmaceutical products.

2002

China

51 - 200 employees

Pharmaceuticals

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9768
Overall
#534
in China
#237
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and exclusionsB-corp & CDP
Financial Data
Business performanceCapital & innovation

View similiar companies


Company logo
BioKangtai

China, Hospital & Health Care, Biotechnology


Company logo
Shandong Buchang Pharmaceuticals

China, Hospital & Health Care, Pharmaceuticals


Company logo
INT Medical Instruments

China, Hospital & Health Care, Medical Device

Market cap

101.3B $, 2025

Revenue

410.0M $, 2026

R&D intensity

13.24% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

101.3B $, 2025▼NaN% YoY

Revenue

410.0M $, FY2026▼NaN% YoY

EBITDA

0.0 $, FY2026▼9.1% YoY

Operating margin

18% Industry: -24▼106.5% YoY

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-153.3M 2024▲198.7% YoY

Capex

165.8M 2024▲49.7% YoY

Debt/equity ratio

0.2 Industry: 0▼NaN% YoY

R&D intensity

13.2%FY2024

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

4.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Available

Workplace health & safety policy

Available

27%
Independent Directors

3 out of 11 incl. management

Powered by illuminem

Overall score

73

Environment

66

Social

93

Governance

60

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

CDP Scores


Climate Score

Not disclosed

Water Score

Not disclosed

A

A-

B

B-

C

C-

D

D-

Powered by illuminem and GIST impact

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email